Back to Search
VASILIOS IOANNIDIS, PHARMD
PHARMD
Pharmacist
NPI: 1336695840Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
RP450843(PA)
Research & Publications (12)
Initiation and limitation of Ly-49A NK cell receptor acquisition by T cell factor-1.
PMID 12847244·J Immunol·2003
7-preclinical
Cre recombinase-mediated inactivation of H-2Dd transgene expression: evidence for partial missing self-recognition by Ly49A NK cells.
PMID 11714788·J Immunol·2001
7-preclinical
The beta-catenin--TCF-1 pathway ensures CD4(+)CD8(+) thymocyte survival.
PMID 11477404·Nat Immunol·2001
7-preclinical
MyHits: improvements to an interactive resource for analyzing protein sequences.
PMID 17545200·Nucleic Acids Res·2007
8-other
Transcriptional regulation of CD4 gene expression by T cell factor-1/beta-catenin pathway.
PMID 16585583·J Immunol·2006
7-preclinical
Comparative transcriptomics of rice reveals an ancient pattern of response to microbial colonization.
PMID 15905328·Proc Natl Acad Sci U S A·2005
4-observational
MyHits: a new interactive resource for protein annotation and domain identification.
PMID 15215405·Nucleic Acids Res·2004
8-other
H-2D ligand expression by Ly49A+ natural killer (NK) cells precludes ligand uptake from environmental cells: implications for NK cell function.
PMID 11714759·J Exp Med·2001
7-preclinical
Inactivation of Notch 1 in immature thymocytes does not perturb CD4 or CD8T cell development.
PMID 11224523·Nat Immunol·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 183 N READING RD, SUITE 9
EPHRATA, PA 17522 - Phone
- (717) 721-5784
Quick Facts
- NPI
- 1336695840
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 12
Are you this provider?
Claim Your Profile